Delivery Order SPE2DB24D2101-SPE2DB25FKPUB
- Not listed
- The Defense Logistics Agency awarded a $1,583.17 delivery order to AmerisourceBergen Drug Corp for DOTAREM 10 MMOL/20 ML vials on July 24, 2025, with an ultimate completion date of July 25, 2025. This is a firm fixed price contract with no set-aside designation, competitively awarded through an open procurement process. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under...
- The Defense Logistics Agency awarded a delivery order valued at $2,563.40 to AmerisourceBergen Drug Corp for DOTAREM 10 mmol/20 ml vials on September 4, 2025, with completion scheduled for September 5, 2025. This firm fixed-price delivery order, which carries no set-aside designation, represents a competitive award to the pharmaceutical distributor for specialized medical supplies supporting federal healthcare needs. The product will be delivered to AmerisourceBergen's corporate office...
- This is a federal contract award from the Defense Logistics Agency (DLA), a defense agency, to Amerisourcebergen Drug Corp, a pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Dotarem 10 mmol/20 ml vials, a medical product. The contract has a ceiling value of $2,406.50 and is a delivery order with a firm fixed price. It is not a set-aside contract. Amerisourcebergen Drug Corp also holds a larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency awarded a $445,640 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4562312526 DOTAREM 10 MMOL/20 ML SYRINGE 20ML. The order was placed under an existing prime vendor contract vehicle and will be performed by Amerisourcebergen at its facility in Conshohocken, Pennsylvania by September 27, 2023. As a leading provider of medical supplies to the Department of Defense, Amerisourcebergen will deliver the requested contrast agent to support...
- The Defense Logistics Agency awarded a $137,720 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4561314100 DOTAREM 7.5 MMOL/15 ML SYRINGE 15ML. As part of its mission to provide logistics support to the Department of Defense, the Defense Logistics Agency issued this order under an existing indefinite-delivery/indefinite-quantity contract vehicle to procure contrast media for diagnostic imaging. Amerisourcebergen will fulfill the order from its facility in...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,594.58 Firm Fixed Price Delivery Order is for the provision of DOTAREM 10 MMOL/20 ML VIAL 20ML, a medical supply product. The contract has a period of performance through March 4, 2024. This award is associated with AmerisourceBergen's $999,999,999 Indefinite Delivery Contract (IDC) with the...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distribution and healthcare solutions provider. The $2,187.08 firm fixed-price delivery order covers the supply of DOTAREM 10 MMOL/20 ML VIAL 20ML, a medical device, to support federal healthcare programs. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA, which serves as a...
- The Defense Logistics Agency awarded a $1,501.90 delivery order to AmerisourceBergen Drug Corp for Gadavist 10 mmol/10 ml vials, with an ultimate completion date of July 21, 2025. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The place of performance is AmerisourceBergen's corporate...
- The Defense Logistics Agency awarded a delivery order valued at $2,961.64 to AmerisourceBergen Drug Corp for Gadavist 10 mmol/10 ml vials. This competitively awarded, firm fixed-price contract represents a non-set-aside procurement and is scheduled for completion by July 21, 2025. The product will be delivered to AmerisourceBergen's corporate headquarters location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA...
- The Defense Logistics Agency awarded a $3,612.16 delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of Gadavist 7.5 mmol/7.5 ml vials. The contract, classified as firm fixed price with no set-aside designation, is scheduled for completion by September 15, 2025, and will be fulfilled from the contractor's facility in Conshohocken, Pennsylvania. This delivery order represents a pediatric or diagnostic imaging pharmaceutical product supporting federal medical...
- SPE2DB24D2101Indefinite Delivery Contract
- SPE2DB24D2101-SPE2DB25FKPUBDelivery Order
The Defense Logistics Agency awarded a $1,894.13 delivery order to AmerisourceBergen Drug Corp on September 19, 2025, for the supply of Dotarem 10 millimol/20 milliliter vials. This competitively awarded, firm fixed-price delivery order is expected to be completed by September 22, 2025, with performance taking place at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical vendor for federal medical procurement across the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company's extensive portfolio of federal contract awards demonstrates its capability to supply a comprehensive range of pharmaceutical products and medical commodities, from brand-name and generic medications to specialty drugs and medical devices across multiple therapeutic domains. This delivery order for Dotarem, a gadolinium-based contrast agent used in magnetic resonance imaging procedures, exemplifies the company's role in supporting military healthcare requirements through the Defense Logistics Agency's pharmaceutical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.9k | 9/19/25 |